These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30515535)

  • 21. Differentiation of hypervascular primary hepatic tumors showing hepatobiliary hypointensity on gadoxetic acid-enhanced magnetic resonance imaging.
    Park HJ; Kim YK; Min JH; Lee J; Lee SJ; Lee ES; Ahn S
    Abdom Radiol (NY); 2019 Sep; 44(9):3115-3126. PubMed ID: 31134313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory myofibroblastic tumours of the liver: gadoxetic acid-enhanced and diffusion-weighted MRI findings with 18F-FDG PET/CT and clinical significance of regression on follow-up.
    Kang TW; Kim SH; Jang KM; Choi D; Choi JY; Park CK
    Clin Radiol; 2014 May; 69(5):509-18. PubMed ID: 24581965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
    Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
    World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should assess MR features.
    Granata V; Grassi R; Fusco R; Setola SV; Belli A; Ottaiano A; Nasti G; La Porta M; Danti G; Cappabianca S; Cutolo C; Petrillo A; Izzo F
    Radiol Med; 2021 Dec; 126(12):1584-1600. PubMed ID: 34843029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
    Choi SY; Kim YK; Min JH; Kang TW; Jeong WK; Ahn S; Won H
    Eur Radiol; 2018 Jun; 28(6):2549-2560. PubMed ID: 29335868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.
    Lu Q; Xue LY; Wang WP; Huang BJ; Li CX
    Abdom Imaging; 2015 Aug; 40(6):1558-66. PubMed ID: 25725793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic enhancement patterns of small-diameter mass-forming intrahepatic cholangiocarcinomas on contrast-enhanced magnetic resonance imaging: Challenges faced by the radiologist.
    Liang W; Wan D; Lu Q; Lin S; Chen Z
    Medicine (Baltimore); 2017 Oct; 96(43):e8351. PubMed ID: 29069015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T.
    Lim S; Kim YK; Park HJ; Lee WJ; Choi D; Park MJ
    J Magn Reson Imaging; 2014 May; 39(5):1238-45. PubMed ID: 24136725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
    Ma X; Liu L; Fang J; Rao S; Lv L; Zeng M; Shi Y; Yang C
    Cancer Imaging; 2020 Jun; 20(1):40. PubMed ID: 32576283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.
    Hwang J; Kim YK; Jeong WK; Choi D; Rhim H; Lee WJ
    Radiology; 2015 Jul; 276(1):137-46. PubMed ID: 25734551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI.
    Kim YK; Lee YH; Kim CS; Lee MW
    Abdom Imaging; 2011 Aug; 36(4):425-32. PubMed ID: 21748468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI.
    Yoon HJ; Kim YK; Jang KT; Lee KT; Lee JK; Choi DW; Lim JH
    Abdom Imaging; 2013 Oct; 38(5):1082-90. PubMed ID: 23508835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging features of hepatic inflammatory pseudotumor: distinction from colorectal liver metastasis using gadoxetate disodium-enhanced magnetic resonance imaging.
    Ichikawa S; Motosugi U; Suzuki T; Shimizu T; Onishi H
    Abdom Radiol (NY); 2020 Aug; 45(8):2400-2408. PubMed ID: 32468212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
    Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
    AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
    Huang B; Wu L; Lu XY; Xu F; Liu CF; Shen WF; Jia NY; Cheng HY; Yang YF; Shen F
    Radiology; 2016 Oct; 281(1):150-7. PubMed ID: 27077381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible?
    Kovač JD; Galun D; Đurić-Stefanović A; Lilić G; Vasin D; Lazić L; Mašulović D; Šaranović Đ
    Acta Radiol; 2017 Dec; 58(12):1417-1426. PubMed ID: 28350257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.
    Yuan MX; Li R; Zhang XH; Tang CL; Guo YL; Guo DY; Luo MK
    Ultraschall Med; 2016 Dec; 37(6):609-618. PubMed ID: 25919414
    [No Abstract]   [Full Text] [Related]  

  • 40. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
    PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.